Literature DB >> 23936591

Skeletal muscle mitochondrial depletion and dysfunction in chronic kidney disease.

Puya G Yazdi1, Hamid Moradi, Jia-Ying Yang, Ping H Wang, Nasratola D Vaziri.   

Abstract

Advanced chronic kidney disease (CKD) is associated with impaired exercise capacity, skeletal muscle dysfunction, and oxidative stress. Mitochondria are the primary source for energy production and generation of reactive oxygen species (ROS). Mitochondrial state 3 respiration, mitochondrial complex I enzyme activity, and tissue porin/actin ratio were determined in the gastrocnemius muscle of male SD rats 14 weeks after 5/6 nephrectomy (CKD) or sham-operation (control). The CKD group exhibited azotemia, hypertension, significant reduction (-39%) of state 3 mitochondrial respiration, and a significant increase in the mitochondrial complex I enzyme activity. The latter is the first step in oxidative phosphorylation, a process linked to production of ROS. These abnormalities were associated with a significant reduction in muscle porin/β actin ratio denoting substantial reduction of mitochondrial mass in skeletal muscle of animals with CKD. CKD results in impaired mitochondrial respiration, reduced muscle mitochondrial mass, depressed energy production and increased ROS generation in the skeletal muscle. These events can simultaneously contribute to the reduction of exercise capacity and oxidative stress in CKD.

Entities:  

Keywords:  End stage renal disease; exercise capacity; muscle weakness; oxidative stress; uremia

Year:  2013        PMID: 23936591      PMCID: PMC3731184     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

Review 1.  In vivo and in organello assessment of OXPHOS activities.

Authors:  Antoni Barrientos
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

Review 2.  The "pro-apoptotic genies" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes.

Authors:  V E Kagan; Y Y Tyurina; H Bayir; C T Chu; A A Kapralov; I I Vlasova; N A Belikova; V A Tyurin; A Amoscato; M Epperly; J Greenberger; S Dekosky; A A Shvedova; J Jiang
Journal:  Chem Biol Interact       Date:  2006-05-12       Impact factor: 5.192

Review 3.  Skeletal muscle dysfunction in chronic renal failure: effects of exercise.

Authors:  Gregory R Adams; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2006-04

4.  ATP production and mechanical work in exercising skeletal muscle: a theoretical analysis applied to 31P magnetic resonance spectroscopic studies of dialyzed uremic patients.

Authors:  G J Kemp; C H Thompson; D J Taylor; G K Radda
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

Review 5.  Ubiquitin-proteasome pathway of intracellular protein degradation: implications for muscle atrophy during unloading.

Authors:  G N DeMartino; G A Ordway
Journal:  Exerc Sport Sci Rev       Date:  1998       Impact factor: 6.230

6.  Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise.

Authors:  J O Holloszy; L B Oscai; I J Don; P A Molé
Journal:  Biochem Biophys Res Commun       Date:  1970-09-30       Impact factor: 3.575

7.  Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle.

Authors:  Parco M Siu; Stephen E Alway
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

8.  Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.

Authors:  Oscar Miró; Ramon M Marrades; Josep Roca; Ernest Sala; Ferran Masanés; Josep M Campistol; Josep V Torregrosa; Jordi Casademont; Peter D Wagner; Francesc Cardellach
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

9.  Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice.

Authors:  Takashi Yokota; Shintaro Kinugawa; Kagami Hirabayashi; Shouji Matsushima; Naoki Inoue; Yukihiro Ohta; Sanae Hamaguchi; Mochamad A Sobirin; Taisuke Ono; Tadashi Suga; Satoshi Kuroda; Shinya Tanaka; Fumio Terasaki; Koichi Okita; Hiroyuki Tsutsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

Review 10.  Mitochondrial reactive oxygen species drive proinflammatory cytokine production.

Authors:  Edwina Naik; Vishva M Dixit
Journal:  J Exp Med       Date:  2011-02-28       Impact factor: 14.307

View more
  29 in total

1.  Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

Authors:  Matthew B Rivara; Catherine K Yeung; Cassianne Robinson-Cohen; Brian R Phillips; John Ruzinski; Denise Rock; Lori Linke; Danny D Shen; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Am J Kidney Dis       Date:  2016-12-04       Impact factor: 8.860

Review 2.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

3.  Effect of Chronic Kidney Disease and Supplemental Polyunsaturated Fatty Acid Use on Exercise Levels During Cardiac Rehabilitation in Patients With Coronary Artery Disease.

Authors:  Adam Pflum; Pallavi Gomadam; Hardik Mehta; Matthew Sacrinty; Connie C Paladenech; Killian Robinson
Journal:  J Cardiopulm Rehabil Prev       Date:  2017-05       Impact factor: 2.081

4.  Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.

Authors:  Trace Thome; Zachary R Salyers; Ravi A Kumar; Dongwoo Hahn; Fabian N Berru; Leonardo F Ferreira; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

5.  FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease.

Authors:  Arvin Halim; Heather N Burney; Xiaochun Li; Yang Li; Claudia Tomkins; Andrew M Siedlecki; Tzong-Shi Lu; Sahir Kalim; Ravi Thadhani; Sharon Moe; Stephen M S Ting; Daniel Zehnder; Thomas F Hiemstra; Kenneth Lim
Journal:  Kidney360       Date:  2022-07-05

Review 6.  Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch; S Russ Price
Journal:  Nat Rev Nephrol       Date:  2021-11-08       Impact factor: 42.439

7.  Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.

Authors:  Danielle L Kirkman; Bryce J Muth; Meghan G Ramick; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

8.  Deficits in the Skeletal Muscle Transcriptome and Mitochondrial Coupling in Progressive Diabetes-Induced CKD Relate to Functional Decline.

Authors:  Daniel C Bittel; Adam J Bittel; Arun S Varadhachary; Terri Pietka; David R Sinacore
Journal:  Diabetes       Date:  2021-02-01       Impact factor: 9.461

9.  Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney disease.

Authors:  Keith G Avin; Meghan C Hughes; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Andrew P Evan; Robert L Bacallao; Michael L Schulte; Ranjani N Moorthi; Debora L Gisch; Christopher G R Perry; Sharon M Moe; Thomas M O'Connell
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

10.  Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction.

Authors:  Aaron J Velasquez-Mao; Mark A Velasquez; Zhengxiong Hui; Denise Armas-Ayon; Jingshen Wang; Moriel H Vandsburger
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.